Lipid-lowering pharmacotherapy history: cholesterol-heart disease link identified ~1960, early treatments failed, statins introduced 1980s (~40 years ago) with benefit but high side effects, limiting prophylactic use; modern era (since ~2015) has seen development of PCSK9 inhibitors, ezetimibe, and bempedoic acid with minimal side effects.
factualpending
Speaker
Peter AttiaEvidence Quote
“what we have today are not just statins... we have other classes of drugs called PCSK9 inhibitors... ezetimibe... bempedoic acid. These are drugs that have no side effects.”
Source
The longevity treatment no one’s talking about: Peter Attia, M.D. | mbg Podcast— the mindbodygreen podcastCreated: 8/12/2026, 6:09:02 PM
Your notes
Loading notes...